This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Stemcell Technologies Canada Inc.. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Michael Riedel: Innovator in Organoid Technology
Introduction
Michael Riedel is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of organoid technology, focusing on methods for obtaining epithelial organoids. With a total of 2 patents, Riedel's work is paving the way for advancements in biomedical research.
Latest Patents
Riedel's latest patents include innovative methods for obtaining organoids. One of his notable patents describes a method for culturing epithelial ducts, duct fragments, and epithelial stem cells in contact with an extracellular matrix. This method utilizes a basal medium that is free of FGF and/or nicotinamide, which is crucial for the successful development of organoids. The organoids obtained through these methods have various applications in research and medicine.
Career Highlights
Michael Riedel is associated with Stemcell Technologies Canada Inc., a company known for its commitment to advancing cell biology research. His work at the company has allowed him to focus on developing cutting-edge techniques that enhance the understanding of organoid biology.
Collaborations
Riedel collaborates with talented individuals in his field, including Charis-Patricia Segeritz and Ryan Conder. These collaborations foster a dynamic environment for innovation and research.
Conclusion
Michael Riedel's contributions to organoid technology are significant and impactful. His innovative methods and collaborations continue to advance the field, making him a notable figure in biomedical research.